Compare ANVS & IPEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANVS | IPEX |
|---|---|---|
| Founded | 2008 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 123.1M |
| IPO Year | 2020 | 2025 |
| Metric | ANVS | IPEX |
|---|---|---|
| Price | $2.54 | $10.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 507.8K | 15.0K |
| Earning Date | 03-20-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $41.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $9.86 |
| 52 Week High | $5.50 | $10.40 |
| Indicator | ANVS | IPEX |
|---|---|---|
| Relative Strength Index (RSI) | 32.52 | N/A |
| Support Level | $2.42 | N/A |
| Resistance Level | $2.81 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 5.27 | 0.00 |
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Inflection Point Acquisition Corp V is a blank check company.